€200Mln CDMO and Pharma investment (2015) by Sanofi for Insulin at Industriepark Höchst in Germany
About this project
CDMO and Pharma investment of € 200 mln by Sanofi at Industriepark Höchst in Germany, Europe, targeting the production of Insulin.
Investment details
| Park | |
|---|---|
| Amount | € 200 mln |
| Categories |
CDMO
chemXplore stats →
Pharma
chemXplore stats →
|
| Investors | 
|
| Target substances |
Insulin
Product
|
Detailed data on 1400+ projects in Europe